1. Introduction {#sec0005}
===============

Renal tumours are known to grow to huge sizes because of their ability to create new vessels to support their growth and their propensity to produce erythropoietin.

In May 2015, The All India Institute of Medical Sciences published the removal of a 5.44 kg renal tumour [@bib0005], [@bib0010] as the largest renal tumour to be removed in the World, thereby surpassing the then existing record of a 2.72 kg removal in New Delhi some time earlier.

This paper describes the collaborative efforts of an experienced team of Urologist, Vascular surgeon and anesthesiologist, supported by a dedicated operating theatre staff and nurses, in removing a 3.63 kg renal tumour, the largest in the Western Hemisphere. This was done on December 02, 2015.

2. Case presentation {#sec0010}
====================

A careful preoperative study and discussion of the CT images, [Fig. 1](#fig0005){ref-type="fig"}, [Fig. 2](#fig0010){ref-type="fig"} is the best preparation, in addition to the clinical examination of the patient. An understanding of the adjacent viscera, especially the vascular structures and close look at the renal vein, vena cava and neo vasculature structures are vital to a successful outcome.

The patient presented with major vascular challenges due to the very large size of the renal vessels and neovasculature, as the tumour impacted the heart by pushing it in a cephalic direction and compromised the left pleural space by causing the diaphragm to be elevated significantly into the left chest.

The tumour pushed the large bowels in all directions as it sought more space for growth.

Our patient had a mitral valve issue as well as scoliosis. The latter condition narrowed down the working space available to the surgeons.

The patient was placed in the "kidney position ' with lumbar elevation and "breaking' the table to open up the lumbar space as much as possible.

Anticoagulation was not used for fear of uncontrollable bleeding.

The incision was started in the thorax in the left bed of the 11th rib, just below the 11th and extended towards the abdominal cavity as far caudally as the umbilicus, [Fig. 3](#fig0015){ref-type="fig"}. No rib resection was needed and the pleural cavity was not opened. An extrapleural approach was maintained throughout the procedure to avoid causing a pneumothorax thereby creating additional respiratory difficulties for the anesthesiologist.

The incision into Gerota's fascia was initiated on the left side of the tumour, [Fig. 4](#fig0020){ref-type="fig"}, remaining well into the perirenal fat and Gerota's fascia, far away as possible from the tumour itself.

This plane was entered and opened up right along this margin to the adrenal area and carried forward over the renal mass.

The adrenal and other vessels from the upper pole of the mass, [Fig. 5](#fig0025){ref-type="fig"}, were carefully separated.

The mass was abutting the pericardial region and a hand was gently persuaded between these structures pulling the renal mass downwards and laterally while sharply dividing all the attachments encountered as well as ligating them carefully.

Attention was next directed at the lower pole and this was mobilized and separated from adjacent bowel and delivered upwards.

At this time attention had to be placed on the pedicle of the mass due to its weight, as its supports were being removed by its dissection.

Any tug on this would avulse the pedicle, causing it to retract behind the large vessels and stemming the torrent of blood would have been life threatening. As such, the weight of the tumour, as it was delivered, was always supported by the hands {and abdomen} of the surgeon and assistant.

The pedicle was then dissected carefully and meticulously.

At surgery, the left renal mass was delivered into the wound by a series of traction and pulsion manoeuvres, [Fig. 6](#fig0030){ref-type="fig"}. The single renal hilar artery and vein were dissected to the aorta and inferior vena cava respectively. They were both very dilated with the vein measuring about 2.5 cm and artery 2 cm. These vessels were skeletonized and transfixed, ligated with 1/0 silk. There was an extensive network of feeding vessels to the mass from surrounding structures. These vessels were all of significant sizes. They were all ligated with 0 vicryl and the tumour delivered and weighed, [Fig. 7](#fig0035){ref-type="fig"}, [Fig. 8](#fig0040){ref-type="fig"}.

The patient's blood loss was estimated at 1200 mls.

His admission Haemoglobin level was 7.1 gm/dl.

Three Units of blood were transfused pre operatively and two units of blood were transfused perioperatively.

Immediate post operative haemoglobin was 10.4 gm/dl.

3. Discussion {#sec0015}
=============

This paper addresses the surgical and anesthetic challenges encountered in removing very large renal tumours.

In this case, the large size of the tumour posed special obstacles to its complete removal.

The patient had scoliosis, which reduced the working space; he also had mitral insufficiency which could have further complicated his operative course and post operative recovery.

Additionally, his left pleural cavity was reduced as the tumour pushed the diaphragm upwards and compromised the cavity.

It also pushed his heart cranially and to the right.

All his adjacent small and large bowels were pushed away as the tumour expanded into the pelvis. Multiple bowel adhesions were encountered.

All these factors were potential comorbid factors that could have hampered a successful outcome.

In such a small island as Trinidad a surgeon's career is at risk as bad news travel quickly in an island and he is tried in the Courts of Public opinion and banished rather expeditiously.

Additionally, the island's population is now well educated in matters medica and access to an abundance of over zealous lawyers willing to sue at no cost to the plaintiff is easy to obtain.

Hence, this type of case is extremely stressful for a Urologist and his team and having this road map to guide another encounter by another team should be very helpful.

4. Pathology of renal mass {#sec0020}
==========================

4.1. Histopathology {#sec0025}
-------------------

The left kidney was 230 × 129 × 175 mm and weighed 3701 g {8.159 lbs}. It was almost completely replaced by a 214 mm tumour which had a smooth bosselated surface and dilated subcapsular vessels. It had a firm solid grey cut surface with irregular zones of necrosis ([Fig. 9](#fig0045){ref-type="fig"}). It was well circumscribed and showed no obvious involvement of the perinephric fat. Only a thin rim of residual renal parenchyma could be seen with obliteration of the calyces.

Histologically, this was a solid tumour formed of spindle cells with ample eosinophilic cytoplasm and ovoid blunt-ended nuclei ([Fig. 10](#fig0050){ref-type="fig"} left). The cells were arranged in interlacing bundles and fascicles. Focally there was increased cellular atypia characterized by enlarged bizarre nuclei and abnormal mitotic figures. There were zones of coagulative necrosis. The mitotic rate was 24 per high power field.

Immunohistochemically, the tumour showed diffuse expression of smooth muscle actin ([Fig. 10](#fig0050){ref-type="fig"} right). It lacked pancytokeratin expression and had no expression of Bcl-2. The tumour was diagnosed as a grade 3 leiomyosarcoma based on the French Federation of Cancer Centres System.

Spindle cell neoplasms of the kidney are not common. The possible diagnoses that were considered included sarcomatoid renal cell carcinoma, synovial sarcoma, leiomyosarcoma, angioleiomyoma, and leiomyoma. The malignant characteristics namely the mitotic rate, atypia and necrosis essentially eliminated the benign diagnoses of leiomyoma and angioleiomyoma. These are both benign mesenchymal tumours with smooth muscle differentiation.

Sarcomatoid renal cell carcinoma (RCC) occurs as a metaplastic transformation of malignant epithelial cells and therefore is not a true sarcoma [@bib0015]. It arises from a preexisting clear cell, papillary, chromophobe or collecting duct RCC. There were no preexisting typical RCC elements in this tumour. Cytokeratin expression supports a diagnosis of sarcomatoid RCC although at times these tumours may altogether loose such expression [@bib0020]. Our tumour had no cytokeratin expression. Generally these tumours display pronounced cytological atypia and do not show the fascicular arrangement seen in this case.

Primary renal synovial sarcoma is a recently described entity [@bib0025]. It may have a spindle cell pattern and is often accompanied by cyst formation. The tumour infiltrates the renal parenchyma and often encircles normal structures. This pattern of invasion was not seen in this lesion. Synovial sarcoma is consistently positive with the Bcl-2, CD99 and vimentin markers [@bib0030]. Our patient's tumour did not display Bcl-2.

Leiomyosarcomas [@bib0025], [@bib0030] (LMS) of the kidney are rare tumours accounting for only 0.5--1% of all renal malignancies. They do, however, represent the most common renal sarcoma accounting for between 50 and 60% of all cases [@bib0035]. Histogenesis remains obscure but they are thought to arise from the renal parenchyma, capsule, main renal vein or smooth muscle of the renal pelvis or rarely from the background of renal angioleiomyoma [@bib0040].

Immunohistochemically the tumour cell express the markers smooth muscle actin, Desmin and h Caldesmon. Most are cytokeratin negative [@bib0045].

The prognosis of LMS is generally poor; 3 year survival rate was 20% and median survival was 18 months in one large series. The importance of grading the tumour is that most tumours with a low grade had relative good prognosis while those with high grade perform poorly [@bib0045], [@bib0050].

5. Conclusion {#sec0030}
=============

Large renal tumours or masses are best approached by the Urologist with an experienced vascular/general surgeon as assistant as well as a skilled anesthetist/Intensivist.

Optimisation, critical care and early mobilization of the patient by a dedicated nursing staff are essential to minimize complications and ensure a successful end result.

The success of this operation underscores what is possible in developing countries.
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![The left renal tumour CT image.](gr1){#fig0005}

![Red arrows on CT images indicate renal mass.](gr2){#fig0010}

![Large Thoraco abdominal incision.](gr3){#fig0015}

![Lateral wall of mass is being mobilized.](gr4){#fig0020}

![Attention now to upper pole as its separated from adrenals.](gr5){#fig0025}

![Lateral and apical margins cleared.](gr6){#fig0030}

![The 8 pounder is now prepared for final delivery.](gr7){#fig0035}

![The specimen weighs in at 8 lbs.](gr8){#fig0040}

![Bisected specimen showing near complete replacement by tumour with yellow/white zones of necrosis.](gr9){#fig0045}

![H&E × 200, left, Spindle cell pattern of tumour cells arranged in fascicles. There is coagulative type necrosis seen in the upper left aspect.\
The immunohistochemical marker Smooth Muscle Actin (SMA), right, shows variably intense but diffuse positivity.](gr10){#fig0050}
